Asia Pacific Anxiety Disorders And Depression Treatment Market Size, Share & Trends Analysis Report By Indication (Anxiety and Depression) By Drugs, By Distribution Channel, By Country and Growth Forecast, 2024

List of Tables

The Asia Pacific Anxiety Disorders And Depression Treatment Market would witness market growth of 4.0% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific Anxiety Disorders And Depression Treatment Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,191.7 million by 2031. The Japan market is registering a CAGR of 3.5% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 4.8% during (2024 - 2031).

The adoption of anxiety disorders and depression treatment has been shaped by various factors that influence how individuals and healthcare systems embrace and implement these therapies. There has been a gradual shift towards greater acceptance of mental health issues as legitimate health concerns.

Moreover, this cultural change has led to more individuals seeking treatment without fear of judgment. The rise of support networks and advocacy groups has empowered individuals to discuss their mental health openly and seek appropriate treatment.

The growth of the pharmaceutical industry in China leads to a wider availability of medications for anxiety and depression. This includes both locally produced and imported antidepressants, anxiolytics, and other therapeutic agents, improving access for Chinese patients. According to the International Trade Administration data, China's pharmaceutical sector has constantly grown and reached $161.8 billion in 2023, taking about 30% of the industry share. The expansion of the pharmaceutical sector drives local drug development, leading to the creation of new and innovative treatments for anxiety and depression.

Based on Indication, the market is segmented into Anxiety and Depression. Based on Drugs, the market is segmented into Antidepressants, Anxiolytics, Anticonvulsants, Noradrenergic Agents, and Atypical Antipsychotics. Based on Distribution Channel, the market is segmented into Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

Pfizer Inc.
GlaxoSmithKline PLC (GSK)
Merck & Co., Inc.
Eli Lilly And Company
AstraZeneca PLC
Bristol-Myers Squibb Company
Johnson & Johnson
AbbVie Inc.
Sanofi S.A.
Takeda Pharmaceutical Company Limited

Asia Pacific Anxiety Disorders And Depression Treatment Market Report Segmentation

By Indication

Anxiety
Depression

By Drugs

Antidepressants
Anxiolytics
Anticonvulsants
Noradrenergic Agents
Atypical Antipsychotics

By Distribution Channel

Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

By Country

China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Asia Pacific Anxiety Disorders And Depression Treatment Market, by Indication
- 1.4.2 Asia Pacific Anxiety Disorders And Depression Treatment Market, by Drugs
- 1.4.3 Asia Pacific Anxiety Disorders And Depression Treatment Market, by Distribution Channel
- 1.4.4 Asia Pacific Anxiety Disorders And Depression Treatment Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Asia Pacific Anxiety Disorders And Depression Treatment Market by Indication

4.1 Asia Pacific Anxiety Market by Country
4.2 Asia Pacific Depression Market by Country

Chapter 5. Asia Pacific Anxiety Disorders And Depression Treatment Market by Drugs

5.1 Asia Pacific Antidepressants Market by Country
5.2 Asia Pacific Anxiolytics Market by Country
5.3 Asia Pacific Anticonvulsants Market by Country
5.4 Asia Pacific Noradrenergic Agents Market by Country
5.5 Asia Pacific Atypical Antipsychotics Market by Country

Chapter 6. Asia Pacific Anxiety Disorders And Depression Treatment Market by Distribution Channel

6.1 Asia Pacific Retail Pharmacies Market by Country
6.2 Asia Pacific Hospital Pharmacies Market by Country
6.3 Asia Pacific Online Pharmacies Market by Country

Chapter 7. Asia Pacific Anxiety Disorders And Depression Treatment Market by Country

7.1 China Anxiety Disorders And Depression Treatment Market
- 7.1.1 China Anxiety Disorders And Depression Treatment Market by Indication
- 7.1.2 China Anxiety Disorders And Depression Treatment Market by Drugs
- 7.1.3 China Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.2 Japan Anxiety Disorders And Depression Treatment Market
- 7.2.1 Japan Anxiety Disorders And Depression Treatment Market by Indication
- 7.2.2 Japan Anxiety Disorders And Depression Treatment Market by Drugs
- 7.2.3 Japan Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.3 India Anxiety Disorders And Depression Treatment Market
- 7.3.1 India Anxiety Disorders And Depression Treatment Market by Indication
- 7.3.2 India Anxiety Disorders And Depression Treatment Market by Drugs
- 7.3.3 India Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.4 South Korea Anxiety Disorders And Depression Treatment Market
- 7.4.1 South Korea Anxiety Disorders And Depression Treatment Market by Indication
- 7.4.2 South Korea Anxiety Disorders And Depression Treatment Market by Drugs
- 7.4.3 South Korea Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.5 Singapore Anxiety Disorders And Depression Treatment Market
- 7.5.1 Singapore Anxiety Disorders And Depression Treatment Market by Indication
- 7.5.2 Singapore Anxiety Disorders And Depression Treatment Market by Drugs
- 7.5.3 Singapore Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.6 Malaysia Anxiety Disorders And Depression Treatment Market
- 7.6.1 Malaysia Anxiety Disorders And Depression Treatment Market by Indication
- 7.6.2 Malaysia Anxiety Disorders And Depression Treatment Market by Drugs
- 7.6.3 Malaysia Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.7 Rest of Asia Pacific Anxiety Disorders And Depression Treatment Market
- 7.7.1 Rest of Asia Pacific Anxiety Disorders And Depression Treatment Market by Indication
- 7.7.2 Rest of Asia Pacific Anxiety Disorders And Depression Treatment Market by Drugs
- 7.7.3 Rest of Asia Pacific Anxiety Disorders And Depression Treatment Market by Distribution Channel

Chapter 8. Company Profiles

8.1 Pfizer, Inc.
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Regional & Segmental Analysis
- 8.1.4 Research & Development Expense
- 8.1.5 SWOT Analysis
8.2 GlaxoSmithKline PLC (GSK)
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Regional Analysis
- 8.2.4 Research & Development Expense
- 8.2.5 SWOT Analysis
8.3 Merck & Co., Inc.
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Segmental and Regional Analysis
- 8.3.4 Research & Development Expenses
- 8.3.5 SWOT Analysis
8.4 Eli Lilly And Company
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Regional Analysis
- 8.4.4 Research & Development Expenses
- 8.4.5 SWOT Analysis
8.5 AstraZeneca PLC
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Regional Analysis
- 8.5.4 Research & Development Expenses
- 8.5.5 SWOT Analysis
8.6 Bristol-Myers Squibb Company
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Regional Analysis
- 8.6.4 Research & Development Expenses
- 8.6.5 SWOT Analysis
8.7 Johnson & Johnson
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Segmental & Regional Analysis
- 8.7.4 Research & Development Expenses
- 8.7.5 SWOT Analysis
8.8 AbbVie, Inc.
- 8.8.1 Company Overview
- 8.8.2 Financial Analysis
- 8.8.3 Regional Analysis
- 8.8.4 Research & Development Expense
- 8.8.5 SWOT Analysis
8.9 Sanofi S.A.
- 8.9.1 Company Overview
- 8.9.2 Financial Analysis
- 8.9.3 Segmental and Regional Analysis
- 8.9.4 Research & Development Expense
- 8.9.5 SWOT Analysis
8.10. Takeda Pharmaceutical Company Limited
- 8.10.1 Company Overview
- 8.10.2 Financial Analysis
- 8.10.3 Regional Analysis
- 8.10.4 Research & Development Expense
- 8.10.5 SWOT Analysis

LIST OF TABLES

TABLE 1 Asia Pacific Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 2 Asia Pacific Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 3 Asia Pacific Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 4 Asia Pacific Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 5 Asia Pacific Anxiety Market by Country, 2020 - 2023, USD Million
TABLE 6 Asia Pacific Anxiety Market by Country, 2024 - 2031, USD Million
TABLE 7 Asia Pacific Depression Market by Country, 2020 - 2023, USD Million
TABLE 8 Asia Pacific Depression Market by Country, 2024 - 2031, USD Million
TABLE 9 Asia Pacific Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 10 Asia Pacific Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 11 Asia Pacific Antidepressants Market by Country, 2020 - 2023, USD Million
TABLE 12 Asia Pacific Antidepressants Market by Country, 2024 - 2031, USD Million
TABLE 13 Asia Pacific Anxiolytics Market by Country, 2020 - 2023, USD Million
TABLE 14 Asia Pacific Anxiolytics Market by Country, 2024 - 2031, USD Million
TABLE 15 Asia Pacific Anticonvulsants Market by Country, 2020 - 2023, USD Million
TABLE 16 Asia Pacific Anticonvulsants Market by Country, 2024 - 2031, USD Million
TABLE 17 Asia Pacific Noradrenergic Agents Market by Country, 2020 - 2023, USD Million
TABLE 18 Asia Pacific Noradrenergic Agents Market by Country, 2024 - 2031, USD Million
TABLE 19 Asia Pacific Atypical Antipsychotics Market by Country, 2020 - 2023, USD Million
TABLE 20 Asia Pacific Atypical Antipsychotics Market by Country, 2024 - 2031, USD Million
TABLE 21 Asia Pacific Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 22 Asia Pacific Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 23 Asia Pacific Retail Pharmacies Market by Country, 2020 - 2023, USD Million
TABLE 24 Asia Pacific Retail Pharmacies Market by Country, 2024 - 2031, USD Million
TABLE 25 Asia Pacific Hospital Pharmacies Market by Country, 2020 - 2023, USD Million
TABLE 26 Asia Pacific Hospital Pharmacies Market by Country, 2024 - 2031, USD Million
TABLE 27 Asia Pacific Online Pharmacies Market by Country, 2020 - 2023, USD Million
TABLE 28 Asia Pacific Online Pharmacies Market by Country, 2024 - 2031, USD Million
TABLE 29 Asia Pacific Anxiety Disorders And Depression Treatment Market by Country, 2020 - 2023, USD Million
TABLE 30 Asia Pacific Anxiety Disorders And Depression Treatment Market by Country, 2024 - 2031, USD Million
TABLE 31 China Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 32 China Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 33 China Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 34 China Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 35 China Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 36 China Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 37 China Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 38 China Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 39 Japan Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 40 Japan Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 41 Japan Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 42 Japan Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 43 Japan Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 44 Japan Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 45 Japan Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 46 Japan Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 47 India Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 48 India Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 49 India Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 50 India Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 51 India Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 52 India Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 53 India Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 54 India Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 55 South Korea Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 56 South Korea Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 57 South Korea Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 58 South Korea Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 59 South Korea Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 60 South Korea Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 61 South Korea Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 62 South Korea Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 63 Singapore Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 64 Singapore Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 65 Singapore Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 66 Singapore Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 67 Singapore Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 68 Singapore Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 69 Singapore Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 70 Singapore Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 71 Malaysia Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 72 Malaysia Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 73 Malaysia Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 74 Malaysia Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 75 Malaysia Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 76 Malaysia Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 77 Malaysia Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 78 Malaysia Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 79 Rest of Asia Pacific Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 80 Rest of Asia Pacific Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 81 Rest of Asia Pacific Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 82 Rest of Asia Pacific Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 83 Rest of Asia Pacific Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 84 Rest of Asia Pacific Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 85 Rest of Asia Pacific Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 86 Rest of Asia Pacific Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 87 Key Information - Pfizer, Inc.
TABLE 88 Key Information - GlaxoSmithKline PLC
TABLE 89 Key Information - Merck & Co., Inc.
TABLE 90 Key Information - Eli Lilly And Company
TABLE 91 Key Information - AstraZeneca PLC
TABLE 92 Key Information - Bristol-Myers Squibb Company
TABLE 93 Key Information - Johnson & Johnson
TABLE 94 Key information - AbbVie, Inc.
TABLE 95 Key Information - Sanofi S.A.
TABLE 96 Key Information - Takeda Pharmaceutical Company Limited

Asia Pacific Anxiety Disorders And Depression Treatment Market Size, Share & Trends Analysis Report By Indication (Anxiety and Depression) By Drugs, By Distribution Channel, By Country and Growth Forecast, 2024 - 2031

Description

Table of Contents